CE Mark for Tyrx absorbable Anti Bacterial Envelope for cardiac procedures - Medtronic
Medtronic, Inc. has received CE (Conformit� Europ�enne) Mark for the Tyrx Absorbable Antibacterial Envelope. This innovative mesh envelope covers an implantable cardiac device to help stabilize the device after implantation and reduce surgical-site infections.
The efficacy of the previous generation, non-absorbable Tyrx Antibacterial Envelope has been shown in three published studies, with new six-month follow-up data from the CITADEL/CENTURION Study presented at Cardiostim 2014.
Six months following implantation, patients who received a single- or dual- chamber implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy (CRT) replacement device with a TYRX Antibacterial Envelope experienced lower infection rates than a historical cohort of patients who were implanted without the envelope.
The Tyrx Antibacterial Envelope was previously marketed as the AIGISRX� Antibacterial Envelope.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins